Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma.

Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM; Undiagnosed Diseases Network, Dhar SU.

Neurol Genet. 2018 Jul 20;4(4):e248. doi: 10.1212/NXG.0000000000000248. eCollection 2018 Aug. No abstract available.

2.

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.

Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R.

Neuro Oncol. 2018 Jul 5. doi: 10.1093/neuonc/noy091. [Epub ahead of print]

PMID:
29982805
3.

Rethinking medulloblastoma from a targeted therapeutics perspective.

Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A.

J Neurooncol. 2018 Jun 5. doi: 10.1007/s11060-018-2917-2. [Epub ahead of print]

PMID:
29869738
4.

Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy.

Ileana Dumbrava E, Smith V, Alfattal R, El-Naggar AK, Penas-Prado M, Tsimberidou AM.

J Immunother. 2018 Sep;41(7):336-339. doi: 10.1097/CJI.0000000000000224.

PMID:
29787423
5.

FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia.

Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002378. doi: 10.1101/mcs.a002378. Print 2018 Apr.

6.

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.

Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr.

J Neurooncol. 2018 Mar;137(1):39-47. doi: 10.1007/s11060-017-2558-x. Epub 2018 Feb 5.

PMID:
29404979
7.

Corrigendum to 'Ependymomas arising outside of the central nervous system: A case series and literature review' [J Clin Neurosci 47 (2018) 202-207].

Yust Katz S, Cachia D, Kamiya-Matsuoka C, Olar A, Theeler B, Penas Prado M, Gilbert MR, Armstrong T.

J Clin Neurosci. 2018 May;51:105. doi: 10.1016/j.jocn.2017.12.011. Epub 2017 Dec 30. No abstract available.

PMID:
29295763
8.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.

van den Bent M, Gan HK, Lassman AB, Kumthekar P, Merrell R, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Bain E, Ansell PJ, Holen KD, Maag D, Reardon DA.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1209-1217. doi: 10.1007/s00280-017-3451-1. Epub 2017 Oct 26.

9.

Ependymomas arising outside of the central nervous system: A case series and literature review.

Yust Katz S, Cachia D, Kamiya-Matsuoka C, Olar A, Theeler B, Penas Prado M, Gilbert MR, Armstrong T.

J Clin Neurosci. 2018 Jan;47:202-207. doi: 10.1016/j.jocn.2017.10.026. Epub 2017 Oct 18. Review. Erratum in: J Clin Neurosci. 2017 Dec 30;:.

PMID:
29054328
10.

CATNON interim results: another triumph of upfront chemotherapy in glioma.

Penas-Prado M, de Groot J.

Neuro Oncol. 2017 Oct 1;19(10):1287-1288. doi: 10.1093/neuonc/nox124. No abstract available.

PMID:
28922864
11.

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.

Penas-Prado M.

Am Soc Clin Oncol Educ Book. 2017;37:187-191. doi: 10.14694/EDBK_175563.

12.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):669-677. doi: 10.1093/neuonc/now208.

13.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M.

Neuro Oncol. 2017 Feb 1;19(2):252-258. doi: 10.1093/neuonc/now236.

14.

NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.

Gilbert MR, Pugh SL, Aldape K, Sorensen AG, Mikkelsen T, Penas-Prado M, Bokstein F, Kwok Y, Lee RJ, Mehta M.

J Neurooncol. 2017 Jan;131(1):193-199. doi: 10.1007/s11060-016-2288-5. Epub 2016 Oct 21.

15.

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.

Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF.

J Neurooncol. 2016 Sep;129(3):487-494. doi: 10.1007/s11060-016-2195-9. Epub 2016 Jul 12.

16.

Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.

Kamiya-Matsuoka C, Cachia D, Waguespack SG, Crane CH, Mahajan A, Brown PD, Nam JY, McCutcheon IE, Penas-Prado M.

Pituitary. 2016 Aug;19(4):415-21. doi: 10.1007/s11102-016-0721-6.

17.

Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report.

Strickland BA, Cachia D, Jalali A, Cykowski MD, Penas-Prado M, Langford LA, Li J, Shah K, Weinberg JS.

Neurosurgery. 2016 Mar;78(3):E466-73. doi: 10.1227/NEU.0000000000001019.

PMID:
26352098
18.

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.

Kim DW, Barcena E, Mehta UN, Rohlfs ML, Kumar AJ, Penas-Prado M, Kim KB.

BMC Cancer. 2015 May 13;15:400. doi: 10.1186/s12885-015-1391-x.

19.

PET-Florbetapir findings in primary cerebral amyloidoma.

Villarejo-Galende A, Sarandeses P, Penas-Prado M, Hernández-Laín A, Ramos A, Hernández-Martínez AC, Carro E, Ricoy JR, Hernández-Gallego J.

J Neurol. 2015;262(4):1052-4. doi: 10.1007/s00415-015-7643-5. Epub 2015 Jan 22. No abstract available.

PMID:
25605437
20.

C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.

Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD.

Brain Tumor Pathol. 2015 Apr;32(2):105-11. doi: 10.1007/s10014-014-0205-1. Epub 2014 Nov 12.

21.

Middle cerebral artery territory infarct due to Cryptococcus infectionstitle: an uncommon indication for cerebrospinal fluid analysis in stroke patients.

Cachia D, Singh C, Tetzlaff MT, Penas-Prado M.

Diagn Cytopathol. 2015 Aug;43(8):632-4. doi: 10.1002/dc.23219. Epub 2014 Oct 28.

PMID:
25352313
22.

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR; MD Anderson Community Clinical Oncology Program; Brain Tumor Trials Collaborative.

Neuro Oncol. 2015 Feb;17(2):266-73. doi: 10.1093/neuonc/nou155. Epub 2014 Sep 19.

23.

Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review.

Farnia B, Allen PK, Brown PD, Khatua S, Levine NB, Li J, Penas-Prado M, Mahajan A, Ghia AJ.

World Neurosurg. 2014 Dec;82(6):1232-41. doi: 10.1016/j.wneu.2014.07.010. Epub 2014 Jul 18.

PMID:
25045788
24.

Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy.

Ghia AJ, Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD.

Neurosurgery. 2013 Oct;73(4):624-30; discussion 630-1. doi: 10.1227/NEU.0000000000000064.

PMID:
23839520
25.

Bevacizumab use in disseminated choroid plexus papilloma.

Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK.

J Neurooncol. 2013 Sep;114(2):251-3. doi: 10.1007/s11060-013-1180-9. Epub 2013 Jun 13. No abstract available.

PMID:
23761024
26.

Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis.

Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R, Penas-Prado M, Groves MD.

J Neurooncol. 2013 Sep;114(2):229-35. doi: 10.1007/s11060-013-1175-6. Epub 2013 Jun 12.

PMID:
23756727
27.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.

Eur J Cancer. 2013 Sep;49(13):2910-8. doi: 10.1016/j.ejca.2013.04.004. Epub 2013 May 10.

PMID:
23668917
28.

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, Brown PD.

Neuro Oncol. 2013 Apr;15(4):406-12. doi: 10.1093/neuonc/nos309. Epub 2013 Jan 14.

29.

Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis.

Ghia AJ, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD.

Neurosurgery. 2013 Feb;72(2):203-9. doi: 10.1227/NEU.0b013e31827b9e68.

PMID:
23149953
30.

Glioblastoma.

Penas-Prado M, Armstrong TS, Gilbert MR.

Handb Clin Neurol. 2012;105:485-506. doi: 10.1016/B978-0-444-53502-3.00004-5. Review. No abstract available.

PMID:
22230514
31.

[Cerebral infarctions and leptomeningeal carcinomatosis].

Sierra-Hidalgo F, Penas-Prado M, Martín-Gil L, Herreros-Rodríguez J, Hilario-Barrio A, Ruiz-Morales J.

Rev Neurol. 2009 Aug 1-15;49(3):156. Spanish. No abstract available.

32.

Spinal cord compression in cancer patients: review of diagnosis and treatment.

Penas-Prado M, Loghin ME.

Curr Oncol Rep. 2008 Jan;10(1):78-85. Review.

PMID:
18366964
33.

Molecularly targeted therapies for malignant gliomas: advances and challenges.

Penas-Prado M, Gilbert MR.

Expert Rev Anticancer Ther. 2007 May;7(5):641-61. Review.

PMID:
17492929
34.

[Post-traumatic supraorbital neuralgia: a benign condition].

Penas-Prado M, Martínez-Salio A, Porta-Etessam J, Villarejo-Galende A, García-Ramos R, Saiz-Díaz RA, Moreno-Ramos T.

Rev Neurol. 2007 Jan 16-31;44(2):89-91. Spanish.

35.

[Spinal epidural abscess in a patient with septicaemia].

Villarejo-Galende A, Camacho-Salas A, Penas-Prado M, Juntas-Morales R, Gonzalez-de la Aleja J, Ramos A, Rodríguez-Vallejo A.

Rev Neurol. 2003 Jun 16-30;36(12):1152-5. Spanish.

36.

[Spontaneous spinal epidural hematoma].

González de la Aleja Tejera J, Penas Prado M, González Martínez V, Rodríguez Peña-Marín M.

Neurologia. 2003 Jun;18(5):285-6. Spanish. No abstract available.

PMID:
12768518
37.

[Unilateral isolated paralysis of the soft palate: a case report and a review of the literature].

Villarejo-Galende A, Camacho-Salas A, Penas-Prado M, García-Ramos R, Mendoza MC, Simón de las Heras R, Mateos-Beato F.

Rev Neurol. 2003 Feb 15-28;36(4):337-9. Review. Spanish.

38.

[Gradenigo syndrome as the form of presentation of nasopharyngeal carcinoma].

Penas-Prado M, Díaz-Guzmán J, Jiménez-Huerta I, Juntas-Morales R, Villarejo-Galende A, Díez-Torres I.

Rev Neurol. 2001 Apr 1-15;32(7):638-40. Spanish.

PMID:
11391492

Supplemental Content

Loading ...
Support Center